End-to-End Regulatory Toxicology Support by Dr. Ramesh Subramani
Are you preparing an IND, NDA, ANDA, or BLA submission for regulatory approval in the US, EU, or other international markets? Gain a strategic advantage with expert consulting from Dr. Ramesh Subramani, a globally recognized Regulatory Toxicologist with over two decades of global experience in nonclinical development and global regulatory submissions.
Dr. Subramani provides customized, science-driven, and regulation-compliant support to help pharmaceutical and biotechnology companies achieve successful preclinical regulatory submissions. His expertise bridges toxicology, safety pharmacology, GLP compliance, and dossier documentation, tailored to meet evolving requirements of US FDA, EMA, MHRA, BfArM, Health Canada, ANVISA, DCGI and emerging markets..